Retraction

APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

see also: https://pubpeer.com/publications/8E3D5FD11BF66A1F2131AC9B23FC49

Citations (13)

13
Total Citations
7
Post-Retraction
(53.8%)
5
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
600 Days since retraction (latest)
Characterization of key genes and immune cell infiltration associated with endometriosis through integrating bioinformatics and experimental analyses
Ying Peng, Xiaoman She, Ying Peng
Hereditas Open Access
Published: Mar 2025
600 days after retraction
RETRACTION: Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma
BioMed Research International
BioMed Research International Open Access
Published: Jan 2025
511 days after retraction
RETRACTION: AK4 Promotes the Progression of HER2‐Positive Breast Cancer by Facilitating Cell Proliferation and Invasion
Disease Markers
Disease Markers Open Access
Published: Jan 2025
511 days after retraction
RETRACTION: The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer
Disease Markers
Disease Markers Open Access
Published: Jan 2025
511 days after retraction
Retraction Note: The role of fibroblast activation protein in progression and development of osteosarcoma cells
Liang Zhang, Li Yang, Zi-Wei Xia et al. (14 authors)
Clinical and Experimental Medicine Open Access
Published: Oct 2023
69 days after retraction
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion: Retraction
Unknown Authors
Anti-Cancer Drugs Open Access
Published: Aug 2023
Same day as retraction
Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma
Yiming Zhang, Wenyi Gan, Nan Ru et al. (8 authors)
Journal of bone oncology Open Access
Published: Apr 2023
11 citations
113 days before retraction
The Apelin/APLNR system modulates tumor immune response by reshaping the tumor microenvironment
Yuqin Yang, Meilin Chen, Yanbing Qiu et al. (6 authors)
Gene
Published: May 2022
16 citations
446 days before retraction
Inflammation-Related Gene Signature: An Individualized Risk Prediction Model for Kidney Renal Clear Cell Carcinoma
Ze Zhang, Wei Yan-yan, Qiongmei Guo et al. (9 authors)
Journal of Oncology Open Access
Published: Jan 2022
8 citations
555 days before retraction
Identification of Gαi3 as a promising target for osteosarcoma treatment
Zheng-jun Bian, Huajian Shan, Yun-Rong Zhu et al. (9 authors)
International Journal of Biological Sciences Open Access
Published: Jan 2022
25 citations
585 days before retraction
Identification of Abnormal Spindle Microtubule Assembly as a Promising Therapeutic Target for Osteosarcoma
Peng Lin, Liyan Liang, Yao‐zhong Dong et al. (6 authors)
Orthopaedic Surgery Open Access
Published: Oct 2020
8 citations
1023 days before retraction
Quick Stats
Total Citations: 13
Years Since Retraction: 2.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Knockdown of CircCRIM1 Inhibits HDAC4 to Impede Osteosarcom…
Cancer Management and Research • 15 citations
miR‑486 suppresses the development of osteosarcoma by regul…
International Journal of Oncology • 33 citations
LncRNA DANCR silence inhibits SOX5-medicated progression an…
Biomedicine & Pharmacotherapy • 38 citations
Identification of ATG7 as a Regulator of Proferroptosis and…
Oxidative Medicine and Cellular Longevity • 15 citations